MedPath

Virtual Reality Study - COVID-19 Protocol

Not Applicable
Completed
Conditions
Healthy Aging
Registration Number
NCT04678778
Lead Sponsor
University of Southern California
Brief Summary

The overarching goal of this pilot clinical trial is to use a novel virtual reality (VR)-based intervention that simultaneously engages physical and cognitive activity aimed at improving brain and cognitive outcomes in older adults. Physical activity is a promising lifestyle intervention for mitigating cognitive decline or delaying onset of dementia. However, to fully leverage beneficial brain effects of physical activity, training the brain to learn and engage in a cognitively stimulating environment may be the key to enhanced brain and cognitive outcomes.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
14
Inclusion Criteria
  • 50-85 Years Old
  • Able to Walk Without Assistance
  • Fluent in English
  • No Ferromagnetic Metal in Body
  • Able to Participate in Moderate Aerobic Physical Activity
Exclusion Criteria
  • Severe Brain Injury/ Head Trauma
  • Pacemakers or Metal Implants
  • Claustrophobia
  • Contradictions to Magnetic Resonance Imaging (MRI)/ Positron Emission Tomography (PET) Brain Scans
  • Opposition to Blood Draws

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Mnemonic Similarity Task for visual memory performance - discrimination index12 weeks

With the study's primary focus on hippocampal function, we will use the Mnemonic Separation Task (MST), a hippocampus-dependent discrimination test of similar objects, as our primary cognitive outcome.

Magnetic Resonance Image (MRI) brain scan of hippocampal volume (cubic mm)12 weeks

The hippocampus has been shown to be a selectively vulnerable region in Alzheimer's Disease (AD), and several studies, including our own, identified a dysfunctional brain signal in the hippocampus in Mild Cognitive Impairment (MCI) patients. We propose to examine the effects of exercise on remediating this hyperactive signal exhibited in MCI patients.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mark and Mary Stevens Neuroimaging and Informatics Institute of the University of Southern California

🇺🇸

Los Angeles, California, United States

Mark and Mary Stevens Neuroimaging and Informatics Institute of the University of Southern California
🇺🇸Los Angeles, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.